International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.01177
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 8, 2019
Authors
Publisher
Frontiers Media SA